Skip to main content
. 2022 Sep 6;12:954037. doi: 10.3389/fonc.2022.954037

Table 2.

Univariate and multivariate survival analysis within Oral Cavity N0 and N+ subgroups.

Oral Cavity NO
  Univariate Multivariate  
  Reference n HR Cl P-Value HR Cl P-Value
Gender Female 119 0.98 (0.49,1.99) 0.96
Smoker No 116 0.78 (0.38,1.59) 0.49
HPV Status Positive 119 1.24 (0.3,5.17) 0.77
Radiation Yes 114 1.94 (0.92,4.1) 0.082
T stage 1,2 119 2.3 (1.12,4.72) 0.023 2.77 (1.32,5.82) 0.0072
Overall Stage I, II 118 2.48 (1.18,5.21) 0.017
Subtype Non-Mesenchymal 119 1.83 (0.89,3.76) 0.099 2.4 (1.14,5.06) 0.021
Age 19-61 119 0.95 (0.48,1.88) 0.88      
Oral Cavity N+
    Univariate  Multivariate
  Reference n HR Cl P-Value HR Cl P-Value
Gender Female 150 1.06 (0.61,1.84) 0.83
Smoker No 146 2.09 (1.03,4.22) 0.041
HPV Positive 150 1 (0.49,2.01) 0.99
Radiation Yes 133 2.12 (1.25,3.6) 0.0053
T stage 1,2 150 2.33 (1.25,4.34) 0.008
Overall Stage I, II 149 2.44 (1.17,5.11) 0.018
Subtype Non-Mesenchymal 150 1.36 (0.84,2.21) 0.22 1.3 (0.79,2.14) 0.3
Age 19-61 150 1.3 (0.81,2.1) 0.28 1.24 (0.76,2.01) 0.39

HR, hazard ratio; CI, confidence interval.